Find uplifting stories about heroes, innovations, and solutions
58 results for "depression treatment"
A Paris hospital has turned donkeys into mental health therapists, and patients say the four-legged caregivers work as well as medication. Since 2016, France's only hospital-based animal therapy unit has helped people with depression, anxiety, and schizophrenia find relief through donkey companionship.
A single infusion of a controversial medication is delivering rapid relief for severe depression in just hours instead of the typical weeks or months traditional treatments require. This breakthrough could transform how doctors help patients in crisis.
New research shows one ketamine infusion can reduce severe depression symptoms within hours, not weeks. For people with treatment-resistant depression, this rapid-acting treatment offers hope when traditional antidepressants fail.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
Seven groundbreaking collaborations between American and Israeli companies just secured $7.5 million to tackle everything from depression treatment to cancer screening in pets. The projects will attract an additional $12.5 million in private investment, bringing real solutions to market faster.
A breakthrough study shows a single dose of psilocybin, combined with therapy, dramatically reduced chronic suicidal thoughts in people who had run out of options. After 12 weeks, 70% of participants reported minimal or no suicidal ideation.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A breakthrough treatment using psilocybin-assisted therapy is nearing FDA approval, offering hope to millions with treatment-resistant depression and PTSD. After decades without new psychiatric treatments, this could revolutionize how we heal mental illness.
UC Davis researchers have developed new compounds that could treat depression and PTSD with the healing power of psychedelics but without hallucinations. The breakthrough discovery uses simple amino acids and UV light to create an entirely new class of mental health treatments.
Scientists have developed a groundbreaking treatment that helps people with depression regain their ability to feel joy, targeting a symptom that affects nearly 90% of patients but is rarely treated directly. The therapy rewires the brain's reward system to rebuild positive emotions, showing better results than conventional approaches.
A Madison nonprofit just became one of three organizations nationwide chosen to speed breakthrough mental health treatments to patients faster. The federal government is slashing review times from up to 10 months down to just one or two.
Researchers discovered exactly how ketamine helps depression and created a safer alternative using three low-dose drugs. The breakthrough could help millions who don't respond to current treatments.
A headset that uses gentle electrical pulses to treat depression just won FDA approval for home use. The device offers a medication-free option for millions struggling with mental health.
A tiny brain implant that treats depression from home just won FDA approval for human trials. The device could help millions who haven't found relief from traditional medications.
A baseball cap that activates a tiny brain implant just won FDA approval for its first human trial. For people with treatment-resistant depression, this could transform morning routines into moments of healing.
A groundbreaking treatment focuses on rebuilding patients' capacity for happiness rather than just reducing negative feelings, showing better results than standard therapy. Nearly 90% of people with depression struggle to feel joy, a symptom most treatments ignore.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Three psychedelic treatments for depression and PTSD could receive FDA approval as soon as this summer, potentially offering hope to millions struggling with mental health conditions. The accelerated review process cuts approval time from a year down to just weeks.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
Virginia lawmakers just passed groundbreaking legislation to help veterans struggling with depression and PTSD. Once the FDA approves psilocybin-based medicine, veterans will have immediate legal access to this promising treatment.
Showing 20 of 58